Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer

Trial Profile

Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 30 Mar 2017

At a glance

  • Drugs Pixantrone (Primary)
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Acronyms ALLIANCE
  • Most Recent Events

    • 13 Jul 2015 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 19 Jun 2012 Actual end date Jan 2012 added as reported by ClinicalTrials.gov.
    • 19 Jun 2012 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top